ASNR21 Virtual: Special Symposium Speaker: Cancer Disparities & COVID-19
Description & Learning Objectives
This session will review cancer and Covid-19 health disparities.
Upon completion of this activity, participants will gain strategies to:
- Recognize cancer health disparities and their effects on health.
-Understand the influence of cancer diagnoses in the risk of Covid-19 infection.
-Review recommendations for achieving health equity to mitigate the potential impact of Covid-19 on preexisting cancer treatment disparities.
Upon completion of this activity, participants will gain strategies to:
- Recognize cancer health disparities and their effects on health.
-Understand the influence of cancer diagnoses in the risk of Covid-19 infection.
-Review recommendations for achieving health equity to mitigate the potential impact of Covid-19 on preexisting cancer treatment disparities.
Instructions for Participation
To complete this activity, learners will watch a recording of a virtual conference session and submit a course evaluation. Once all elements are completed, a certificate will be automatically added to your transcript.
Credit Dates
Available: 5/23/2021
Expires: 5/22/2024
Expires: 5/22/2024
Planners & Faculty
ASNR would like to thank the following individuals for planning this activity:
Planner: Tina Young Poussaint, MD, FACR
Moderator: Michele Johnson, MD, FACR
ASNR also would like to recognize the ASNR21 Program Committee:
Tina Young Poussaint, MD, Program Chair
Peter Chang, MD
J. Levi Chazen, MD
Nancy Fischbein, MD
Wende Gibbs, MD, MA
Michele Johnson, MD, FACR, FASER
Michael Lev, MD, FAHA, FACR
James Milburn, MD
Michelle Silvera, MD
Jason Talbott, MD, PhD
Christopher Whitlow, MD, PhD, MHA
Richard Wiggins, MD
Planner: Tina Young Poussaint, MD, FACR
Moderator: Michele Johnson, MD, FACR
ASNR also would like to recognize the ASNR21 Program Committee:
Tina Young Poussaint, MD, Program Chair
Peter Chang, MD
J. Levi Chazen, MD
Nancy Fischbein, MD
Wende Gibbs, MD, MA
Michele Johnson, MD, FACR, FASER
Michael Lev, MD, FAHA, FACR
James Milburn, MD
Michelle Silvera, MD
Jason Talbott, MD, PhD
Christopher Whitlow, MD, PhD, MHA
Richard Wiggins, MD
Agenda
Introduction: Johnson B. Lightfoote, MD, FACR
Cancer Disparities & COVID-19: Otis W, Brawley, MD, MACP, FASCO, FACE
Cancer Disparities & COVID-19: Otis W, Brawley, MD, MACP, FASCO, FACE
Accreditation Statement
The American Society of Neuroradiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Neuroradiology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society of Neuroradiology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure
In compliance with ACCME requirements and guidelines, ASNR has developed a policy for disclosure and review of potential conflicts of interest and a method for resolution if a conflict does exist. ASNR maintains a tradition of scientific integrity and objectivity in its educational activities. In order to preserve these values and ensure its educational activities are independent and free of commercial bias, all individuals, including planners, presenters, moderators and evaluators, participating in an ASNR educational activity, or an activity jointly provided by ASNR must disclose all relevant financial relationships with ineligible companies, as defined by the ACCME. Unless listed below, all planners and individuals in control of content have nothing to disclose.
Johnson, Michele: IschiemiaView, Scientific/Medical Advisory Board Member
Brawley, Otis: Lyell Immunopharma, Corporate Board Member; PDSs Bioscience, Corporate Board Member; Grail, Consultant; Jackson Laboratories, Corporate Board Member; Genentech/Roche, Consultant
Chang, Peter: Avicenna.ai, Stock shareholder
Johnson, Michele: IschiemiaView, Scientific/Medical Advisory Board Member
Lev, Michael: Takeda Pharm, Consultant; GE Healthcare, Research Grant Site Principal Investigator
Poussaint, Tina Young: NIH: Pediatric Brain Tumor Consortium Neuroimaging Center Grant, Research Grant Site Principal Investigator; Springer Publishing, Other Financial or Material Support
Schwartz, Erin Simon: Applied Radiology, Editor in Chief
All other participants and planners have no disclosures.
Johnson, Michele: IschiemiaView, Scientific/Medical Advisory Board Member
Brawley, Otis: Lyell Immunopharma, Corporate Board Member; PDSs Bioscience, Corporate Board Member; Grail, Consultant; Jackson Laboratories, Corporate Board Member; Genentech/Roche, Consultant
Chang, Peter: Avicenna.ai, Stock shareholder
Johnson, Michele: IschiemiaView, Scientific/Medical Advisory Board Member
Lev, Michael: Takeda Pharm, Consultant; GE Healthcare, Research Grant Site Principal Investigator
Poussaint, Tina Young: NIH: Pediatric Brain Tumor Consortium Neuroimaging Center Grant, Research Grant Site Principal Investigator; Springer Publishing, Other Financial or Material Support
Schwartz, Erin Simon: Applied Radiology, Editor in Chief
All other participants and planners have no disclosures.
